About 28 results
Open links in new tab
  1. Sweet Holey Pillow Dreams - Medscape

    Jun 20, 2022 · The next day, I received the diagnosis: chondrodermatitis nodularis helicis (CNH). I looked it up. Right on.

  2. Dermatology, April 2006 - Page 2 - Medscape

    Apr 1, 2006 · Chondrodermatitis nodularis helicis (CNH) is a chronic, friction-induced inflammatory lesion classically occurring on the helix or antihelix and attributed to multiple factors, including …

  3. White Papules on the Ear - Medscape

    Jul 31, 2003 · What is your diagnosis? Chondrodermatitis nodularis helicis Xanthomata Gout Amyloid View the correct answer.

  4. Nonmalignant Photodamage - Medscape

    A review of aging-related skin problems, including sallowness, wrinkles, solar lentigos, and other benign conditions.

  5. Vixarelimab Safe and Effective in Prurigo Nodularis - Medscape

    In a randomized clinical trial, vixarelimab demonstrates dose-dependent, long-term safety and efficacy in patients with prurigo nodularis.

  6. Nemolizumab Approved for AD, Prurigo Nodularis in Europe

    Feb 19, 2025 · Nemolizumab “is also the first and only biologic approved for atopic dermatitis and prurigo nodularis with 4-week dosing intervals from the start of treatment,” according to the …

  7. Nemolizumab Shows Lasting Benefits in Prurigo Nodularis

    Mar 25, 2025 · Long-term nemolizumab use reduces itch, disease severity, and steroid dependence in patients with prurigo nodularis in a Japanese trial.

  8. Case Reports Describe Itch Relief With Nemolizumab - Medscape

    Jul 25, 2025 · In recently reported case studies, nemolizumab, approved for two indications associated with itch, has been reported to be effective in alleviating itch in a variety of other …

  9. Several Skin Diseases Increase Among Transplant Patients

    A retrospective study finds a higher prevalence of several autoimmune and inflammatory conditions, in addition to skin cancers, among solid organ transplant recipients.

  10. MHRA Approves Nemolizumab for Eczema and Prurigo Nodularis

    Feb 18, 2025 · The MHRA has granted marketing authorisation to nemolizumab to treat prurigo nodularis in adults and atopic dermatitis in people aged 12 and over.